Share-Based Compensation (Tables)

9 Months Ended

Nov. 02, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Below is a summary of stock option activity for the thirty-nine weeks ended November 2, 2013:



Stock Options	Number of Underlying Shares		Weighted-Average Exercise Price		Aggregate Intrinsic Value		Weighted-Average Remaining Contractual Life
Outstanding at February 2, 2013	569,400		$	65.40
Granted	—		—
Exercised	(7,500	)	28.24
Forfeited or expired	(23,800	)	76.01
Outstanding at November 2, 2013	538,100		$	65.44	$	1,048,700	3.5
Stock options exercisable at November 2, 2013	538,100		$	65.44	$	1,048,700	3.5
Stock options expected to become exercisable in the future as of November 2, 2013	—		—		—		—

Schedule of Weighted-Average Estimated Fair Value and Assumptions of Stock Appreciation Rights

The weighted-average estimated fair value of stock appreciation rights granted during the thirty-nine week periods ended November 2, 2013 and October 27, 2012, and the weighted-average assumptions used in calculating such fair value, on the date of grant, were as follows:



	Thirty-Nine Weeks Ended
	Chairman and Chief Executive Officer				Other Executive Officers						All Other Associates
	November 2, 2013	October 27, 2012			November 2, 2013			October 27, 2012			November 2, 2013			October 27, 2012
Grant date market price	—	$	—		$	46.57		$	52.89		$	45.46		$	52.02
Exercise price	—	$	—		$	46.57		$	52.89		$	45.46		$	52.02
Fair value	—	$	—		$	20.34		$	23.53		$	16.82		$	22.21
Assumptions:
Price volatility	—	—		%	61		%	56		%	54		%	59		%
Expected term (years)	—	—			4.7			5.0			4.1			4.1
Risk-free interest rate	—	—		%	0.7		%	1.3		%	0.6		%	0.9		%
Dividend yield	—	—		%	1.8		%	1.1		%	1.8		%	1.1		%

Schedule of Stock Appreciation Rights Activity

Below is a summary of stock appreciation rights activity for the thirty-nine weeks ended November 2, 2013:



Stock Appreciation Rights	Number of Underlying Shares		Weighted-Average Exercise Price		Aggregate Intrinsic Value		Weighted-Average Remaining Contractual Life
Outstanding at February 2, 2013	9,246,859		$	40.17
Granted:
Chairman and Chief Executive Officer	—		—
Other Executive Officers	189,700		46.57
All Other Associates	105,500		45.46
Exercised	(510,875	)	31.99
Forfeited or expired	(33,600	)	49.97
Outstanding at November 2, 2013	8,997,584		$	40.80	$	34,277,453	3.7
Stock appreciation rights exercisable at November 2, 2013	2,991,261		$	46.03	$	3,696,298	4.4
Stock appreciation rights expected to become exercisable in the future as of November 2, 2013	5,957,158		$	38.11	$	30,578,924	3.4

Schedule of Restricted Stock Unit Activity

Below is a summary of restricted stock unit activity for the thirty-nine weeks ended November 2, 2013:



Restricted Stock Units	Number of Underlying Shares		Weighted-Average Grant Date Fair Value
Unvested at February 2, 2013	1,198,680		$	46.88
Granted ⁽¹⁾	782,400		42.52
Vested	(358,728	)	40.65
Forfeited	(135,479	)	45.68
Unvested at November 2, 2013	1,486,873		$	46.29

⁽¹⁾

Number of shares granted includes approximately 240,000 shares related to the grant of performance share awards ("PSAs") in Fiscal 2013. This reflects the target amount granted; however, the number of PSAs that ultimately are earned would vary from 0% - 200% of target depending on the level of growth of adjusted diluted earnings per share. The number also includes 15,000 of additional shares earned above the Fiscal 2012 target due to the achievement above target.